Primary radiotherapy
• Stage I/II: Low/intermediate risk
– BRACHYTHERAPY alone
• Stage I/II: High risk
• Stage III & IV
– External beam to CTV including whole
uterus and pelvic nodes: 45 - 50.4Gy
– BRACHYTHERAPY boost